INDIVIDUAL-DIFFERENCES IN THE ORIENTATION OF THE CYTOLYTIC T-CELL RESPONSE AGAINST MOUSE-TUMOR P815

被引:54
作者
BRICHARD, VG
WARNIER, G
VANPEL, A
MORLIGHEM, G
LUCAS, S
BOON, T
机构
[1] LUDWIG INST CANC RES,BRUSSELS BRANCH,UCL 7459,B-1200 BRUSSELS,BELGIUM
[2] UNIV CATHOLIQUE LOUVAIN,CELL GENET UNIT,B-1200 BRUSSELS,BELGIUM
关键词
P815; TUMOR ANTIGEN; CYTOLYTIC T LYMPHOCYTES;
D O I
10.1002/eji.1830250306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We reported previously that the mouse tumor P815 expresses four distinct antigens (A, B, C, D) recognized by syngeneic cytolytic T lymphocytes (CTL). A fifth P815 antigen (E) was identified by means of a CTL done derived from tumor-infiltrating lymphocytes. We compared a number of mice for the orientation of their CTL response with respect to the various P815 antigens. Lymphocytes from mice inoculated subcutaneously with living P815 cells were stimulated in vitro with tumor cells and the resulting CTL were tested against targets expressing either antigens A and B or antigens C, D and E. Many mice had an asymmetrical response, some producing CTL directed almost exclusively against antigens A, B and others producing CTL directed almost exclusively against C, D. E. When mice were inoculated into two separate sites, different orientations in the responses of the two local lymph nodes were often observed, suggesting that individual differences in the orientation of the anti-P815 CTL response do not result from preexisting differences between the animals. Asymmetrical CTL responses persisted in mice that were given a second injection of tumor cells. A possible interpretation of our results is that the major component of the CTL response is made of the progeny of a very small number of CTL precursors that happen to be the first to be stimulated by the tumor antigens.
引用
收藏
页码:664 / 671
页数:8
相关论文
共 25 条
[1]   REJECTION BY SYNGENEIC MICE OF CELL VARIANTS OBTAINED BY MUTAGENESIS OF A MALIGNANT TERATOCARCINOMA CELL LINE [J].
BOON, T ;
KELLERMANN, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (01) :272-275
[2]   IMMUNOGENIC VARIANTS OBTAINED BY MUTAGENESIS OF MOUSE MASTOCYTOMA P815 .2. LYMPHOCYTE-T-MEDIATED CYTOLYSIS [J].
BOON, T ;
VANSNICK, J ;
VANPEL, A ;
UYTTENHOVE, C ;
MARCHAND, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (05) :1184-1193
[4]   GENERATION OF CYTOTOXIC T LYMPHOCYTES INVITRO .1. RESPONSE OF NORMAL AND IMMUNE MOUSE SPLEEN-CELLS IN MIXED LEUKOCYTE-CULTURES [J].
CEROTTINI, JC ;
ENGERS, HD ;
MACDONALD, HR ;
BRUNNER, KT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (03) :703-717
[5]   CLONAL EXPANSION OF T-CELLS - A CYTOTOXIC T-CELL RESPONSE INVIVO THAT INVOLVES PRECURSOR CELL-PROLIFERATION [J].
DENIZOT, F ;
WILSON, A ;
BATTYE, F ;
BERKE, G ;
SHORTMAN, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :6089-6092
[6]  
DUNN TB, 1957, J NATL CANCER I, V18, P587
[7]   LONGITUDINAL ANALYSIS OF T-CELL RECEPTOR (TCR) GENE USAGE BY HUMAN IMMUNODEFICIENCY VIRUS-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE CLONES REVEALS A LIMITED TCR REPERTOIRE [J].
KALAMS, SA ;
JOHNSON, RP ;
TROCHA, AK ;
DYNAN, MJ ;
NGO, HS ;
DAQUILA, RT ;
KURNICK, JT ;
WALKER, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1261-1271
[8]   CYTOLYTIC T-CELL CLONES AGAINST AN AUTOLOGOUS HUMAN-MELANOMA - SPECIFICITY STUDY AND DEFINITION OF 3 ANTIGENS BY IMMUNOSELECTION [J].
KNUTH, A ;
WOLFEL, T ;
KLEHMANN, E ;
BOON, T ;
ZUMBUSCHENFELDE, KHM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2804-2808
[9]   MOUSE-TUMOR REJECTION ANTIGEN-P815A AND ANTIGEN-P815B - 2 EPITOPES CARRIED BY A SINGLE PEPTIDE [J].
LETHE, B ;
VANDENEYNDE, B ;
VANPEL, A ;
CORRADIN, G ;
BOON, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) :2283-2288
[10]   HLA CLASS-I GENE-EXPRESSION ON HUMAN PRIMARY TUMORS AND AUTOLOGOUS METASTASES - DEMONSTRATION OF SELECTIVE LOSSES OF HLA ANTIGENS ON COLORECTAL, GASTRIC AND LARYNGEAL CARCINOMAS [J].
LOPEZNEVOT, MA ;
ESTEBAN, F ;
FERRON, A ;
GUTIERREZ, J ;
OLIVA, MR ;
ROMERO, C ;
HUELIN, C ;
RUIZCABELLO, F ;
GARRIDO, F .
BRITISH JOURNAL OF CANCER, 1989, 59 (02) :221-226